Form 4/A for ICCC IMMUCELL CORP /DE/
Accepted 2025-12-04 00:00:00 ET · period of report 2025-12-03 · accession 0001437749-25-036913 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | 2025-12-04 | 2025-12-03+ | ICCC | te Boekhorst Paul Francis Olivier | Pres, CEO, Dir | P - Purchase | $5.23 | +6,030 | 9,738 | +163% | +$31.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock $0.10 par value per share | 2025-12-03 | P | A | 3,598 | $5.05 | 7,306 | D | — | — | (F1) This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased. |
| 2 | Common | Common Stock $0.10 par value per share | 2025-12-04 | P | A | 2,432 | $5.50 | 9,738 | D | — | — | (F2) This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased, and the correct transaction date. |